CSIMarket
 


Rocket Pharmaceuticals Inc   (RCKT)
Other Ticker:  
 

Rocket Pharmaceuticals Inc 's Tangible Leverage Ratio

RCKT's quarterly Tangible Leverage Ratio and Total Liabilities, Tangible Equity growth


Due to repayements of liabilities of -1.93% Rocket Pharmaceuticals Inc improved Tangible Leverage Ratio in third quarter 2023 to 0.12, below the company's average Tangible Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the third quarter 2023, 24 other companies have achieved lower Tangible Leverage Ratio than Rocket Pharmaceuticals Inc in the III Quarter 2023. While Tangible Leverage Ratio total ranking has improved so far in the third quarter 2023 to 80, from total ranking in the second quarter 2023 at 228 .

Explain Tangible Leverage Ratio?
What is RCKT Market Share?
What are RCKT´s Total Liabilities?


RCKT Tangible Leverage Ratio (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity Change 41.69 % -5.26 % 1.86 % 0.21 % -26.02 %
Y / Y Total Liabilities Change 15.46 % 33.19 % 31.39 % 46.87 % 12.04 %
Tangible Leverage Ratio MRQ 0.12 0.17 0.14 0.15 0.15
RCKT's Total Ranking # 80 # 228 # 261 # 103 # 347
Seq. Tangible Equity Change 41.02 % -14.19 % -7.25 % 26.24 % -5.71 %
Seq. Total Liabilities Change -1.93 % 5.24 % -10.04 % 24.36 % 13.13 %



Tangible Leverage Ratio third quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 47
Overall Market # 80


Tangible Leverage Ratio Statistics
High Average Low
1.13 0.34 0.03
(Dec 31 2017)   (Sep 30 2015)




Financial Statements
Rocket Pharmaceuticals Inc 's Tangible Equity $ 477 Millions Visit RCKT's Balance sheet
Rocket Pharmaceuticals Inc 's Total Liabilities $ 58 Millions Visit RCKT's Balance sheet
Source of RCKT's Sales Visit RCKT's Sales by Geography


Cumulative Rocket Pharmaceuticals Inc 's Tangible Leverage Ratio

RCKT's Tangible Leverage Ratio for the trailling 12 Months

RCKT Tangible Leverage Ratio

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Tangible Equity TTM Growth 41.69 % -5.26 % 1.86 % 0.21 % -26.02 %
Y / Y Total Liabilities TTM Growth 15.46 % 33.19 % 31.39 % 46.87 % 12.04 %
Tangible Leverage Ratio TTM 0.14 0.15 0.14 0.13 0.12
Total Ranking TTM # 2 # 2 # 225 # 83 # 247
Seq. Tangible Equity TTM Growth 41.02 % -14.19 % -7.25 % 26.24 % -5.71 %
Seq. Total Liabilities TTM Growth -1.93 % 5.24 % -10.04 % 24.36 % 13.13 %


On the trailing twelve months basis Due to repayements of liabilities of -1.93% Rocket Pharmaceuticals Inc decreased Tangible Leverage Ratio in the 12 months ending in III Quarter 2023 to 0.14, below the company's average Tangible Leverage Ratio.
Tangible Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Major Pharmaceutical Preparations industry 24, during the past 12 months, other companies have achieved lower Tangible Leverage Ratio than Rocket Pharmaceuticals Inc . While total ranking remained unchanged compared to previous 12 month period at no. 2.

Explain Tangible Leverage Ratio?
What is RCKT Market Share?
What are RCKT´s Total Liabilities?

TTM Tangible Leverage Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 25
Healthcare Sector # 47
Within the Market # 2


trailing twelve months Tangible Leverage Ratio Statistics
High Average Low
1.13 0.34 0.03
(Dec 31 2017)   (Sep 30 2015)




Companies with similar Tangible Leverage Ratio in the quarter ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Tangible Leverage RatioSep 30 2023 MRQ Total LiabilitiesSep 30 2023 MRQ Tangible Equity
Kronos Bio Inc   0.33 $ 59.373  Millions$ 178.620  Millions
Verve Therapeutics Inc   0.33 $ 152.038  Millions$ 460.369  Millions
Arbutus Biopharma Corp  0.33 $ 39.304  Millions$ 119.337  Millions
Abcellera Biologics Inc   0.33 $ 329.415  Millions$ 1,010.893  Millions
Nurix Therapeutics Inc   0.32 $ 74.378  Millions$ 233.817  Millions
Shuttle Pharmaceuticals Holdings Inc   0.31 $ 1.766  Millions$ 5.610  Millions
Phio Pharmaceuticals Corp   0.31 $ 2.256  Millions$ 7.213  Millions
Anaptysbio Inc   0.31 $ 37.437  Millions$ 120.383  Millions
Stoke Therapeutics Inc   0.31 $ 53.500  Millions$ 172.999  Millions
Protagenic Therapeutics Inc new  0.31 $ 1.280  Millions$ 4.153  Millions
Pepgen Inc   0.31 $ 38.406  Millions$ 125.865  Millions
Alx Oncology Holdings Inc  0.30 $ 51.355  Millions$ 168.752  Millions
Xilio Therapeutics inc   0.30 $ 15.915  Millions$ 52.498  Millions
Clever Leaves Holdings Inc   0.30 $ 8.088  Millions$ 26.868  Millions
Monopar Therapeutics Inc   0.30 $ 1.982  Millions$ 6.611  Millions
Annexon Inc   0.30 $ 46.977  Millions$ 156.839  Millions
Y mabs Therapeutics inc   0.29 $ 28.734  Millions$ 97.430  Millions
Annovis Bio inc   0.29 $ 1.926  Millions$ 6.658  Millions
Homology Medicines Inc  0.29 $ 25.292  Millions$ 88.211  Millions
Corcept Therapeutics Inc  0.29 $ 132.343  Millions$ 461.679  Millions
Dermata Therapeutics Inc   0.29 $ 1.834  Millions$ 6.407  Millions
Inozyme Pharma Inc   0.28 $ 45.489  Millions$ 160.213  Millions
Allakos Inc   0.28 $ 62.452  Millions$ 221.043  Millions
Lipella Pharmaceuticals Inc   0.28 $ 0.619  Millions$ 2.222  Millions
Siga Technologies Inc  0.28 $ 34.240  Millions$ 123.242  Millions
Sunshine Biopharma Inc   0.27 $ 5.687  Millions$ 20.747  Millions
Neurobo Pharmaceuticals Inc   0.27 $ 5.784  Millions$ 21.550  Millions
Imunon Inc   0.27 $ 4.846  Millions$ 18.072  Millions
Cara Therapeutics inc   0.26 $ 22.384  Millions$ 85.642  Millions
Lianbio  0.26 $ 60.564  Millions$ 236.112  Millions

Date modified: 2023-11-08T18:20:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com